Sign in

Pierre Santucci

@pierresantucci.bsky.social
820 followers 1.2K following 48 posts

PI CNRS - Aix Marseille Université 🇫🇷🇪🇺 All about Mycobacteria, Pathogenesis & Antibiotics 🦠🧫🔬💊 pierre-santucci.owlstown.net

PostsRepliesMedia
Pierre Santucci @pierresantucci.bsky.social · 7h
💥 Very happy to share our latest preprint completing the CRISPRi trilogy of the lab! 📃📃📃 We used CRISPRi to engineer mycobacterial hypomorphs that are conditionally hyper-resistant or hyper-vulnerable to anti-TB drugs such as INH & ETH ✂️💊🏴‍☠️🧫🦠 Kudos to Eliana, Sofia & Mika for leading the work! 💪👏👌🥳
020
Reposted by Pierre Santucci
Madhu Pai, MD, PhD @madhupai.bsky.social · 06/10/2026
Deputy Director, TB Delivery Gates Foundation gatesfoundation.wd1.myworkdayjobs.com/Gates/job/Se...
036
Reposted by Pierre Santucci
Max Gutierrez @maxgg.bsky.social · 06/10/2026
💥Very happy to see this work out! Fantastic work from former PhD student Beren Aylan on single cell dynamic reporters in Mtb using unstable mWasabi. So many people helped along the way, in particular Laure Botella, Pierre Santucci @pierresantucci.bsky.social Tony Fearns and Teresa Cortes 🥳
1173
Reposted by Pierre Santucci
Mickaël Blaise @mickael-blaise.bsky.social · 05/10/2026
Dear all, our postdoctoral job offer (24 months) to study cellular biology of Nocardia species poorly explored human pathogenic bacteria, is now open it IRIM, Montpellier France. Starting date January 2027 (negotiable). Please see the job description and procedure to apply here : lnkd.in/epMMMKBM
lnkd.in
LinkedIn
This link will take you to a page that’s not on LinkedIn
112
Reposted by Pierre Santucci
Ákos T Kovács @evolvedbiofilm.bsky.social · 17/09/2026
Maxence Vincent @maxencevincent.bsky.social on Bacterial strategies in response to immune oxidative attacks #EMBOBacNet
121
Reposted by Pierre Santucci
Journal of Cell Biology @jcb.org · 31/08/2026
To escape or not to escape, that is the question. Ya-Cheng Liao and Claudio Bussi @claudiobussi.bsky.social discuss new work by Sergi Marco et al. from Jim C. Norman's group (doi.org/10.1083/jcb....) in Spotlight: rupress.org/jcb/article/...
0112
Reposted by Pierre Santucci
Journal of Cell Science @jcellsci.bsky.social · 19/08/2026
A common LRRK2 variant sensitises macrophages to cell stress Highlighting papers from Rebecca Morrison, Enrica Pellegrino, Sila Ultanir, @maxgg.bsky.social & colleagues and @andresgoldman.bsky.social, @mitodynamics.bsky.social @theneuro.bsky.social & team. journals.biologists.com/jcs/article/...
195
Reposted by Pierre Santucci
Jens Hör @jenshoer.bsky.social · 10/08/2026
Do you need to analyze bacterial microscopy data and are looking for an all-in-one tool for Windows or macOS? Check out BactoMate by Lasse Hallenga and Philipp Popp! I'm happy that we were able to contribute to this great work. www.biorxiv.org/content/10.6...
biorxiv.org
BactoMate: an integrated platform for reproducible bacterial microscopy analysis
Quantitative microscopy of microorganisms increasingly produces large, multidimensional datasets, yet their analysis often depends on fragmented workflows spanning file conversion, segmentation, quali...
04020
Reposted by Pierre Santucci
Soldati Lab @soldatilab.bsky.social · 29/07/2026
New preprint from the lab! 🎉 Using the Dictyostelium–M. marinum infection model, we reveal ancient roles for STAT-like factors in vacuole integrity and host defence. Congratulations to the team! 🦠🔬 @j-toinon.bsky.social @nabilhanna3.bsky.social www.biorxiv.org/content/10.6...
173
Reposted by Pierre Santucci
Nathan Day @nthndy.bsky.social · 28/07/2026
Very pleased to announce that my Crick postdoc work has just been published in Nature Communications: www.nature.com/articles/s41... Big thank you to @bpradel.bsky.social, @jaksonluk.bsky.social, @maxgg.bsky.social and the rest of the host-pathogen interactions in TB lab that made it all possible!
nature.com
Fast-growing intracellular Mycobacterium tuberculosis populations evade antibiotic treatment - Nature Communications
The slow growth displayed by Mycobacterium tuberculosis has been historically associated with pathogen’s persistence and drug tolerance. Unexpectedly, here the authors identify a rare subpopulation of...
22311
Reposted by Pierre Santucci
Christophe 🔬 Leterrier @christlet.bsky.social · 17/07/2026
🚨 Want to start your lab in Marseille on a broad neuronal/brain development theme? There's an exciting tenure track opportunity at @inp-marseille.bsky.social and others Marseille institutes! Check more details here: neuro-marseille.org/en/blog/juni... or contact me if you have any question
23136
Reposted by Pierre Santucci
Ben Engel @cellarchlab.com · 03/07/2026
Super excited to launch this search for a new endowed professor at the @biozentrum.unibas.ch! Join us to build a research cluster in Climate Biophysics! 🌍🌊🌾🔬🧪 This is a unique opportunity to create a community in Basel🇨🇭working together on this timely topic! ⏳🌡️ Questions? Please reach out! 👩‍🔬👨‍🔬
14947
Reposted by Pierre Santucci
PLOS Biology @plosbiology.org · 05/06/2026
The T6SS is a widespread nanoweapon deployed by #bacteria, but why is it deployed heterogeneously? @cascaleslab.bsky.social &co show that #Ecoli adopt distinct #T6SS attacker "ON" & defender "OFF" roles to optimize survival, a key strategy in microbial warfare @plosbiology.org 🧪 plos.io/3S5dL45
Top: Representative confocal fields of the 3 types of TssC-GFP-TssK microcolonies (homogeneous ON, heterogeneous, homogeneous OFF). Scale bars, 10 μm. Bottom:  Model for the role of T6SS phenotypic heterogeneity in EAEC. Top: The Psci1 promoter integrates Fur- and Dam-dependent regulation, generating ON (T6SS⁺, yellow) and OFF (T6SS⁻, blue) subpopulations at a reversible equilibrium. Bottom left: OFF (blue) cells, which do not express T6SS, do not kill competitors but avoid triggering such defences (1). Due to the absence of killing activity, OFF cells are unable to colonize the niche (2). Bottom centre: While ON (yellow) cells assemble and deploy functional T6SS (1) and kill susceptible competitors (2), they provoke retaliatory attacks from defensive T6SS⁺ species (gray) and are eliminated and fail to colonize the niche (3). Bottom right: Heterogeneous ON/OFF population (1) optimizes colonization by killing neighboring cells (2). While ON (yellow) cells are eliminated by counterattacks by defensive T6SS+ species (gray), OFF (blue) cells resist (3) and can ensure a continuous supply of ON cells (4-5) while limiting population-wide exposure to retaliation.
1269
Reposted by Pierre Santucci
Cascales Lab @cascaleslab.bsky.social · 05/06/2026
Happy to share the last work of Jonas Desjardins, identifying and characterizing a novel Rhs NAD(P) glycohydrolase delivered by the #T6SS of the major cosmetic contaminant, Pluralibacter gergoviae. www.jbc.org/article/S002...
03210
Reposted by Pierre Santucci
Maxence Vincent @maxencevincent.bsky.social · 03/06/2026
👇👇👇 NEW PREPRINT ONLINE 👇👇👇 www.biorxiv.org/content/10.6... #NewPreprint #Microbiology #Inflammation #GutMicrobiome
3119
Reposted by Pierre Santucci
Rémi Fronzes @fronzeslab.bsky.social · 26/05/2026
New preprint. In S. sanguinis, a C5a peptidase-like protease (ScpH) polymerizes along eDNA, turning it into a catalytic biofilm scaffold. Great work from @robinanger.bsky.social in our lab, with Pelicic lab @lcbofficiel.bsky.social www.biorxiv.org/content/10.6...
312044
Reposted by Pierre Santucci
UK Cellular Microbiology @ukcellmicro.bsky.social · 05/05/2026
Deadline approaching: Submit an abstract until 12th of May to present at the UK Cellular Microbiology Meeting 2026! Great opportunity for early career researchers! www.ukcellmicro.org
034
Reposted by Pierre Santucci
Angélique Perret @angieprrt.bsky.social · 09/04/2026
🧵 Tiny organisms, big advantages!
241
Reposted by Pierre Santucci
The Francis Crick Institute @crick.ac.uk · 02/04/2026
Don’t miss out on More Questions of Science. We’ve recorded six bonus episodes, revisiting some of the biggest themes from previous episodes of A Question of Science Listen to all six brand-new episodes on your favourite podcast platform: www.lnk.to/AQuestionOfScienceBB
More Questions of Science graphic logo with the Francis Crick Institute and BBC Studios logos.
074
Reposted by Pierre Santucci
Lis Lowe @lislowe.bsky.social · 27/03/2026
We’ve been sciencing! M abscessus makes a arabinanase toxin to chop up the cell wall of competitor mycobacteria! #glycotime 🦠 thanks to @wellcometrust.bsky.social for the funding that makes this collaborative work possible! Also Sam’s structures are 😍 and Jean-Lou did some lovely biochem
23110
Reposted by Pierre Santucci
Patrick Moynihan @pmoyniha.bsky.social · 27/03/2026
We've been we've been working on this for quite a while now (hopefully published soon). Grateful to @proftracypalmer.bsky.social for concinving me & @lislowe.bsky.social that mycobacteria produce inter-bacterial toxins. Team science, led by @sambenedict5.bsky.social www.biorxiv.org/content/10.6...
biorxiv.org
44826
Reposted by Pierre Santucci
Luiz Pedro Carvalho, PhD @luizcarvalholab.bsky.social · 25/03/2026
All currently approved antibiotics inhibit essential cellular processes. Ever wonder if we could kill bacteria using the opposite strategy? Here, we demonstrate an alternative antibacterial strategy: lethality through pathway over-activation. www.nature.com/articles/s41... (1 out of 3)
nature.com
Activation of l-histidine biosynthesis as a new antibiotic strategy against Mycobacterium tuberculosis - Nature Communications
Here, the authors report metabolic activation as a potential antimicrobial strategy against Mycobacterium tuberculosis. They show that supra-physiological activation of L-histidine biosynthesis r...
66832
Reposted by Pierre Santucci
The Francis Crick Institute @crick.ac.uk · 23/03/2026
“I think it’s a real mistake to forget where the pipeline for all this begins.” John Diffley reflects on the importance of basic research, his mission to decode DNA replication and recreate it in the lab, and the scientific optimism of the 1960s that helped shape it. www.crick.ac.uk/news/2026-03...
39143
Reposted by Pierre Santucci
Institut Pasteur | 130 years of biomedical research @pasteur.fr · 23/03/2026
🧬 EMBO Workshop – The complexity of mycobacterial infections: from research to real-world impact 📅 14–18 Sept 2026, Paris Tuberculosis & non-tuberculous mycobacteria at the heart of discussions: evolution, host–pathogen interactions, drug resistance. 🔗 meetings.embo.org/event/26-myc...
Tuberculosis (TB), caused by Mycobacterium tuberculosis, remains one of the deadliest infectious diseases worldwide. Meanwhile, non-tuberculous mycobacteria (NTM) are an increasing global health concern. NTM infections often resemble TB clinically, which can lead to misdiagnosis and inappropriate therapy. Additionally, drug-resistant strains of M. tuberculosis and NTM exacerbate the global antimicrobial resistance crisis. A better understanding of the biology of mycobacterial pathogens and of the mechanisms underlying disease pathogenesis and transmission is critical to reduce their burden worldwide.

This EMBO Workshop is the fourth in a successful series held at the Institut Pasteur in Paris, following the meetings organized in 2012, 2016, and 2022. It will bring together scientists, clinicians, public health experts, and representatives from industry and non-profit organizations, who will share recent insights into mycobacterial infections, from fundamental discoveries to translational research, and their practical implications. The program will cover mycobacterial evolution, physiology, metabolism, host–pathogen interactions, immune responses, mechanisms of drug evasion, therapeutic strategies, vaccines, and diagnostics. Emerging experimental models, computational approaches, and artificial intelligence will also be addressed, showing how recent technologies contribute to advancing mycobacterial research and interventions.
1911
Reposted by Pierre Santucci
EMBL-EBI @ebi.embl.org · 16/03/2026
You asked, we listened. Millions of AI-predicted protein complex structures are now available in the #AlphaFold Database. This spans homodimers from 20 of the most studied species, including humans, as well as the World Health Organization’s priority pathogens list. www.ebi.ac.uk/about/news/t...
816087
Reposted by Pierre Santucci
Alexandre Gouzy @alexandregouzy.bsky.social · 11/03/2026
I’m pleased 🤗 to share our new preprint exploring the mode of action and resistance of the antitubercular drug pyrazinamide (PZA) 💊 Thanks to everyone who have participated 🙌 We hope these findings will help the fight against drug resistance in tuberculosis. www.biorxiv.org/content/10.6...
43320
Reposted by Pierre Santucci
John Rubinstein @johnrubinstein.bsky.social · 06/03/2026
I've written a review on what I think is an extremely exciting direction in cryo-EM: Cryo-EM of endogenous membrane proteins in their native lipid bilayer Open access in Quarterly Reviews of Biophysics: doi.org/10.1017/S003...
Figure 1. Cryo-EM of abundant protein complexes in native membranes.Figure 2. Cryo-EM of membrane proteins in vesicles.Figure 3. 3D reconstruction of V-ATPase in native synaptic vesicle membranes.Figure 4. Generation of membrane vesicles for structure determination of proteins in their native lipid bilayer.
317765
Reposted by Pierre Santucci
febsopenbio.bsky.social @febsopenbio.bsky.social · 20/02/2026
⏰️ Missed the deadline to submit? Don't worry! 🙌 Our Call for Papers on Host-Pathogen Interactions has now extended to 11 March 2026. 🦠 Take this extra time to submit your work on host-pathogen communications/interaction, pathogen tolerance and resistance mechanisms ➡️ buff.ly/NwTaoan
011
Reposted by Pierre Santucci
Badreddine Douzi @badreddinedouzi.bsky.social · 18/02/2026
Happy to share a new review proposing a unified nomenclature for T4SSs. Great collaboration with Peter J Christie, Gabriel Waksman, Ronnie Per-Arne Berntsson and our team. academic.oup.com/femsre/artic... #T4SS#Microbiology
academic.oup.com
Type IV secretion systems: reconciling diversity through a unified nomenclature
This review presents a comprehensive overview of Type IV Secretion Systems (T4SSs), focusing on their structural, functional, and evolutionary diversity ac
02115
Reposted by Pierre Santucci
Alvaro Schwalb @aschwalbc.bsky.social · 13/02/2026
1/📢 In our new publication, we estimate that in 2022, 134 million people worldwide had a recent Mycobacterium tuberculosis (Mtb) infection and were at high risk of progressing to TB disease. Read the full paper in PLOS Medicine (tinyurl.com/mtbinfection). #TBSky
tinyurl.com
Estimating the global burden of viable Mycobacterium tuberculosis infection: A mathematical modelling study
Alvaro Schwalb and colleagues conducted a mathematical modelling study to estimate the global burden of viable Mycobacterium tuberculosis--that which can cause disease and be transmitted--to help guid...
23825
Reposted by Pierre Santucci
Mélanie Foulon @mel-foulon.bsky.social · 12/02/2026
🚨 New preprint! Together with @carobarisch.bsky.social lab, we investigated how intracellular compartmentalization shapes lipid acquisition in mycobacteria Interestingly, deleting one FACL enzyme (FACL6) revealed striking compartment-dependent phenotypes 🔬 Check it out: doi.org/10.64898/202...
22211
Reposted by Pierre Santucci
Maxence Vincent @maxencevincent.bsky.social · 11/02/2026
Unveiling hidden variables in stressed bacteria: Cell Reports www.cell.com/cell-reports...
cell.com
Unveiling hidden variables in stressed bacteria
Noise in bacterial stress responses is often dismissed as mere randomness. While true stochasticity exists, much variation reflects hidden variables—cell state, history, and microenvironment—that are ...
3118
Reposted by Pierre Santucci
Nature Communications @natcomms.nature.com · 02/02/2026
#Microbiology The anti-tuberculosis drug bedaquiline targets the mycobacterial ATP synthase, but how that leads to bacterial death is unclear Here the authors clarify how bedaquiline works @jnblab.bsky.social @morwan.me #TBSky #antibiotics #AMR dlvr.it/TQjZ0W
Cartoon representing the mycobacterial oxidative phosphorylation system, including cytochromes, NDH-2, and ATP synthase. Taken from Figure 1 of the article.
33721
Reposted by Pierre Santucci
BioImagingUK @bioimaginguk.bsky.social · 02/02/2026
🔬UK researchers: Access cutting-edge bioimaging tech + expert support with our User Access Fund! 💷 £5k for imaging 💷 £2k for image analysis Choose from 6 top UK facilities, contact them, then apply! rms.org.uk/user-access-fund ⏰ Next deadline: 31 March ✅ Decision in 4 weeks Pls share!
11514
Reposted by Pierre Santucci
The Company of Biologists @biologists.bsky.social · 29/01/2026
Throughout the year, our community has been sharing stories with us about how The Company of Biologists has supported you over time. Your stories were heartfelt, and we feel grateful and humbled that we have been able to be part of your journeys. bit.ly/4q7C0Ki
Message in a bottle

Stories on how The Company of Biologists supports the biological community
2179
Reposted by Pierre Santucci
Victor de Lorenzo (CNB, Madrid) @vdlorenzo.bsky.social · 27/01/2026
How do you react when your favorite microbe is renamed by taxonomists who are completely outside your field—and who ignore the community that actually works with it? Here is our clear answer re the case of Pseudomonas putida KT2440 👉🏻 journals.asm.org/doi/10.1128/...
journals.asm.org
The disputed identity of Pseudomonas putida KT2440: when taxonomists rename your favorite microbe | mBio
Names matter; they are not mere labels. They operate as anchors of memory, social coordinates, and references of collective identity. When a name becomes established through long-term use and broad ad...
23314
Reposted by Pierre Santucci
Joachim Goedhart @joachimgoedhart.bsky.social · 27/01/2026
Join us in Amsterdam for a FEBS advanced course on "Functional Imaging of cellular dynamics" from 31st of May - 6th of June 2026 Info: microscopy2026.febsevents.org
Flyer with announcement of the FEBS advanced course in Amsterdam
02416
Reposted by Pierre Santucci
Teresa Thurston @thurstonlab.bsky.social · 26/01/2026
We are looking for a new RA to join our team working on host-pathogen interactions during Salmonella infection. The appointment is for two years and you will join a diverse team, using cell and protein biochemistry to further our understanding of pathogenesis. my.corehr.com/pls/uoxrecru...
my.corehr.com
Job Details
0817
Reposted by Pierre Santucci
Ricardo Henriques @henriqueslab.bsky.social · 15/01/2026
📯👨‍🚀 Calling all #bioimage analysis aficionados. #EZInput is out! We wanted to bring #ImageJ’s capacity to record settings to the #Python ecosystem 🐍. It is a declarative library for generating UIs that just work. Done with @guijacquemet.bsky.social lab arxiv.org/abs/2601.08859 #ScientificComputing
24515
Reposted by Pierre Santucci
Olivier Neyrolles @oneyrolles.bsky.social · 13/01/2026
🥳 𝐄𝐱𝐜𝐢𝐭𝐞𝐝 𝐭𝐨 𝐬𝐡𝐚𝐫𝐞 𝐨𝐮𝐫 𝐥𝐚𝐭𝐞𝐬𝐭 𝐰𝐨𝐫𝐤 𝐬𝐡𝐨𝐰𝐢𝐧𝐠 𝐡𝐨𝐰 𝐩𝐨𝐥𝐲𝐬𝐢𝐚𝐥𝐲𝐥𝐚𝐭𝐢𝐨𝐧, 𝐚 𝐫𝐚𝐫𝐞 𝐩𝐫𝐨𝐭𝐞𝐢𝐧 𝐦𝐨𝐝𝐢𝐟𝐢𝐜𝐚𝐭𝐢𝐨𝐧, 𝐫𝐞𝐠𝐮𝐥𝐚𝐭𝐞𝐬 𝐢𝐧𝐟𝐥𝐚𝐦𝐦𝐚𝐭𝐨𝐫𝐲 𝐦𝐨𝐧𝐨𝐜𝐲𝐭𝐞 𝐦𝐨𝐛𝐢𝐥𝐢𝐳𝐚𝐭𝐢𝐨𝐧 𝐟𝐫𝐨𝐦 𝐭𝐡𝐞 𝐛𝐨𝐧𝐞 𝐦𝐚𝐫𝐫𝐨𝐰. ✍️ Aurélien Boyancé, Nelly Gilles, @yoannrombouts.bsky.social & coll. @ipbstoulouse.bsky.social 📖 shorturl.at/IDwza 👇 A short thread...
21910
Reposted by Pierre Santucci
The Company of Biologists @biologists.bsky.social · 09/01/2026
Journal of Cell Science @jcellsci.bsky.social is recruiting an enthusiastic and motivated Reviews Editor. An exciting opportunity for a talented scientific editor to make a contribution to an important journal in the field of #cellbiology. Deadline 2 Feb. More at: www.biologists.com/about-us/wor...
biologists.com
Work for us
Working for us We’re always looking for talented and motivated people to work as part of our close-knit team. Roles range from editorial to production, marketing to event co-ordination, HR to accounts...
01219
Reposted by Pierre Santucci
Angélique Perret @angieprrt.bsky.social · 04/01/2026
🚨 Want to know how we demonstrated the importance of sterol-rich membrane microdomains for M. marinum infection? Check out our latest paper published in Science Advances 👇 www.science.org/doi/10.1126/... ✨ Big thanks to everyone, especially Cristina Boehm-Bosmani, @soldatilab.bsky.social ! ✨
science.org
Membrane microdomains are crucial for Mycobacterium marinum EsxA-dependent membrane damage, escape to the cytosol, and infection
Sterol-rich microdomain accumulation at the MCV is crucial for Mm-induced damage and infection in D. discoideum and BV-2 cells.
4227
Reposted by Pierre Santucci
The Company of Biologists @biologists.bsky.social · 25/12/2025
To accelerate the publication process, @biologyopen.bsky.social are testing an initiative that prioritises fast but fair peer review. This approach pays reviewers while requiring them to complete high-quality reviews in a set timeframe. Apply to be a reviewer www.biologists.com/bio-fast-and...
Fast & Fair peer review. A new initiative offering high-quality peer review within 7 working days of submission.
0195
Reposted by Pierre Santucci
Luiz Pedro Carvalho, PhD @luizcarvalholab.bsky.social · 22/12/2025
We’re excited to share our latest study that reshapes our understanding of Mycobacterium tuberculosis (Mtb) lipid composition, with major implications for drug discovery, immunity, and vaccine development. www.nature.com/articles/s41... A thread.
nature.com
Mycobacterium tuberculosis overcomes phosphate starvation by extensively remodelling its lipidome with phosphorus-free lipids - Nature Communications
Here, the authors show that Mycobacterium tuberculosis manipulates lipid metabolism to overcome host restriction, by remodelling its lipidome and utilising host lipids as an alternative phosphate sour...
149530
Reposted by Pierre Santucci
Bryan Bryson @thebrysonlab.bsky.social · 18/12/2025
Two pieces of fun news: 1. We've launched a new website for our lab: www.brysonlab.org 2. With some new funding, we are recruiting for new postdocs and graduate students. The projects build upon our previous studies of antigen presentation and phagosome biology and go into new exciting dimensions!
brysonlab.org
The Bryson Lab | Vaccine Development & Research at MIT
Developing effective accessible vaccines to end tuberculosis worldwide. Combining immunoengineering, molecular microbiology & systems biology at MIT.
24125
Reposted by Pierre Santucci
David Cleary @bacterioskeptic.bsky.social · 18/12/2025
As my own three year stint as an Editor comes to an end I cannot recommend doing this enough
044
Reposted by Pierre Santucci
Jan-Willem Veening @veeninglab.com · 18/12/2025
I'm not sure what to think about this. Most top open access journals cost more than CHF 3,500 to publish so will not be covered by SNSF funding. It will make it even more difficult for small universities to publish in top journals because of budget limitations.
041
Reposted by Pierre Santucci
Amel Latifi @latifilab.bsky.social · 17/12/2025
How do simple cells make complex patterns? We discovered a key piece in cyanobacteria—an ancient enzyme repurposed to activate a pattern-forming signal. A conserved signaling strategy, showing how nature reuses tools to build multicellularity. www.cell.com/iscience/ful...
cell.com
Co-option of an ancestral peptidase controls developmental patterning in multicellular cyanobacteria
Developmental biology
3126
Reposted by Pierre Santucci
Catalin Bunduc @catalinbunduc.bsky.social · 12/12/2025
🚨PhD position alert🚨 🔬Cryo-EM? ✅ 🧫Membrane proteins? - we've got 165 TMs for you! ✅ Join me and the team👥 in beautiful Amsterdam🚴 to untangle the amazing mycobacterial protein secretion machinery! 📝Apply here: tinyurl.com/mmxnfpnw 📆Deadline: 23 January #PhDstudent #T7SS #cryoEM #newPI
tinyurl.com
Vacature — PhD candidate; Mechanism and assembly of type VII secretion system machineries
We are looking for an enthusiastic and motivated PhD candidate to join Dr. Catalin Bunduc’s team in the Molecular Microbiology Section of the Amsterdam Institute for Life and Environment (A-LIFE).
0913